Literature DB >> 3349606

Cis-4-decenoic acid in plasma: a characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency.

M Duran1, L Bruinvis, D Ketting, J B de Klerk, S K Wadman.   

Abstract

The profile of organic acids in plasma of patients with a deficiency of medium-chain acyl-CoA dehydrogenase (EC 1.3.99.3) was determined by gas-liquid chromatography of trimethylsilylated derivatives of the acids isolated by ethyl acetate extraction. All 13 patients had increased concentrations of free octanoate, cis-4-decenoate, and decanoate in their plasma. Cis-4-decenoate, an intermediary metabolite of linoleic acid, is pathognomonic of medium-chain acyl-CoA dehydrogenase deficiency. This metabolite does not accumulate in plasma after oral loading with medium-chain triglycerides, in contrast to octanoate and decanoate. Two postmortem plasma samples from victims of infant sudden-death syndrome had detectable octanoate and decanoate, but cis-4-decenoate could not be detected. The identification of cis-4-decenoate in plasma may be an aid in the diagnosis of an inherited defect in oxidation of medium-chain fatty acids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349606

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  The detection of abnormal metabolites in MCAD deficiency: a new method.

Authors:  W Blom; A C Polder-Mol; H H Kelholt-Dijkman; L Hierck; J G Huijmans
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: report of two siblings.

Authors:  C Catzeflis; C Bachmann; D E Hale; P M Coates; U Wiesmann; J P Colombo; F Joris; G Délèze
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

3.  Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle.

Authors:  Alethea G Barschak; Gustavo da C Ferreira; Karina R André; Patrícia F Schuck; Carolina M Viegas; Anelise Tonin; Carlos S Dutra Filho; Angela T S Wyse; Clóvis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2006-04-28       Impact factor: 3.584

4.  Cerebrospinal fluid organic acids in biotinidase deficiency.

Authors:  M Duran; E R Baumgartner; T M Suormala; L Bruinvis; L Dorland; J A Smeitink; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Intermediates of unsaturated fatty acid oxidation are incorporated in triglycerides but not in phospholipids in tissues from patients with mitochondrial beta-oxidation defects.

Authors:  W Onkenhout; V Venizelos; H R Scholte; J B De Klerk; B J Poorthuis
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

6.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

Authors:  J L Van Hove; W Zhang; S G Kahler; C R Roe; Y T Chen; N Terada; D H Chace; A K Iafolla; J H Ding; D S Millington
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

7.  Evidence that antioxidants prevent the inhibition of Na+,K(+)-ATPase activity induced by octanoic acid in rat cerebral cortex in vitro.

Authors:  Dênis R de Assis; César A J Ribeiro; Rafael B Rosa; Patricia F Schuck; Karina B Dalcin; Carmen R Vargas; Clóvis M D Wannmacher; Carlos S Dutra-Filho; Angela T S Wyse; Paz Briones; Moacir Wajner
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

8.  Rapid diagnosis of medium-chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in plasma.

Authors:  S J Heales; D A Woolf; P Robinson; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

9.  Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient.

Authors:  R Moore; J F Glasgow; M A Bingham; J A Dodge; R J Pollitt; S E Olpin; B Middleton; K Carpenter
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

10.  Holocarboxylase synthetase deficiency: early diagnosis and management of a new case.

Authors:  A Fuchshuber; T Suormala; B Roth; M Duran; D Michalk; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.